HAEM4:B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities
Revision as of 13:09, 3 November 2023 by Bailey.Glen (talk | contribs) (Created page with "{{Under Construction}} ==Primary Author(s)*== Put your text here __TOC__ ==Graphical Data Links== Put your graphics here ==General Disease Overview / Description of Canc...")
This page is under construction |
Primary Author(s)*
Put your text here
Graphical Data Links
Put your graphics here
General Disease Overview / Description of Cancer Category
Put your text here
WHO Classification Pages (Includes Links to Content)
- B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1
- B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged
- B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1
- B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy
- B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy
- B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3
- B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1
- B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like
- B-Lymphoblastic Leukemia/Lymphoma with iAMP21
- B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified
Other Related Pages (Includes Links to Content)
- B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4
- B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6
- B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)
- B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions
- B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)
Additional Information
Put your text here
References
(use "Cite" icon at top of page)
EXAMPLE Book
- Arber DA, et al., (2008). Acute myeloid leukaemia with recurrent genetic abnormalities, in World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edition. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, Editors. IARC Press: Lyon, France, p117-118.
Notes
*Primary authors will typically be those that initially create and complete the content of a page. If a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section, please contact the CCGA coordinators (contact information provided on the homepage). Additional global feedback or concerns are also welcome.
*The hierarchical tumour classification structure displayed on this page is reproduced from the WHO Classification of Tumours with permission from the copyright holder, ©International Agency for Research on Cancer.